{'fraction_non_alphanumeric': 0.03486750348675035, 'fraction_numerical': 0.026499302649930265, 'mean_word_length': 4.653543307086614, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
Efficacy of high dose interferon--alpha treatment of chronic hepatitis B.

Fifteen consecutive Hepatitis B virus chronic hepatitis patients were treated with interferon alfa-2B 10 mu tiw for 5-6 months. All patients could tolerate the side effects without serious complications throughout the treatment period. Overall, 12 cases had normalization of ALT (80%), 7 cases had loss of HbeAg with appearance of anti-Hbe (58.33%) and 2 cases had loss of HbsAg with the presence of antiHBs (13.33%). The response usually associated with improvement in histology and decrease in viral load. These results seemed to be better than other studies with a lower dose. Further study with more patients should be done in the future.